ATTD: Advanced Technologies and Treatments for Diabetes
ATTD: Advanced Technologies and Treatments for Diabetes
Podcast Description
ATTD is the ultimate forum to discover the latest diabetes research, devices, therapies and developments worldwide. This show, “ATTD Conference Catch-up”, will use AI podcasting to extract key insights from expert presentations and research discussions, transforming them into short, easy-to-digest episodes for busy healthcare professionals like you. So if you’re a diabetes specialist, researcher, or industry leader, this podcast is made for you.
Hit subscribe, and let’s explore the future of diabetes treatment, one breakthrough at a time.
Podcast Insights
Content Themes
The podcast focuses on the latest advancements in diabetes research and treatment, covering topics such as gene therapy, continuous glucose monitoring, and innovative technology applications in diabetes management, with specific episodes discussing beta cell therapies and the role of AI in diabetes care.
ATTD is the ultimate forum for the latest in diabetes research, technology, and clinical innovation. This podcast channel offers two types of content designed for busy healthcare professionals:
* ATTD Conference Catch-up: Short, AI-generated episodes with key insights from expert presentations and research discussions at the ATTD Conference.
* Curated Series: In-depth, human-led conversations on topics like Long-Acting Insulin Uncovered, featuring expert interviews and real-world stories, supported by Eli Lilly.
Whether you’re a specialist, researcher, or industry leader, hit subscribe.
In today’s episode Ginger Vieria is joined by Diana Isaacs, PharmD, and Endocrine Clinical Pharmacist, to dive deeper into the pharmacokinetics and pharmacodynamics of long-acting insulin.
They explore how long-acting insulin can improve blood glucose levels, reduce the burden of daily injections, and simplify insulin management for the person with diabetes.
Diana Isaacs is a diabetes advocate and speaker. She’s a Director in Education & Training in Diabetes Technology at the Cleveland Clinic, and she’s also a Fellow of the Association of Diabetes Care and Education Specialists (FADCES) and the American College of Clinical Pharmacy (FCCP).
If you’d like to dive deeper into today’s topic, don’t miss our CME/CPD accredited e-learning course, titled Breaking New Ground: Once-Weekly Insulin.
The session delves into the evolution of long-acting insulin therapy and introduces groundbreaking once-weekly formulations. 1 CME/CPD Credit available.
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.